World / Diabetes
Nearly Nine Out Of Ten Patients With Type 2 Diabetes Achieve QoF HbA1c Targets With Repaglinide And Metformin
31.08.2008 04:22
medicalnewstoday.com
Nearly nine out of ten patients with type 2 diabetes achieved the Quality Outcomes Framework (QoF) HbA1c target of â¤7.5% with a repaglinide [PRANDIN®] and metformin treatment strategy says a new study review published in Clinical Therapeutics1.
World
Diabetes
Amylin Pharmaceuticals And Eli Lilly Provide Context For FDA Alert For BYETTA
31.08.2008 04:22
medicalnewstoday.com
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) in a conference call today provided context and additional information regarding the August 18, 2008 U.S. Food and Drug Administration (FDA) update to a prior alert for BYETTA(R) (exenatide) injection referencing pancreatitis. The companies were aware of the pancreatitis cases referenced in the alert, as well as others, and previously reported these cases to the FDA.
World
Diabetes
« Previous
0
Next »
English